Publications by authors named "D Ahangari"
[A case of Sweet syndrome in a patient receiving erlotinib for lung adenocarcinoma].
Ann Dermatol Venereol
March 2020
Article Synopsis
- Sweet syndrome is a skin condition characterized by neutrophilic inflammation, often occurring without a known cause, but can be related to medications or certain cancers.
- This case report details the first instance of Sweet syndrome appearing in a patient with lung adenocarcinoma after starting treatment with erlotinib.
- The findings suggest a potential link between the use of the EGFR tyrosine kinase inhibitor and the development of Sweet syndrome, marking a novel connection not previously documented in medical literature.